The Pharmacy and Poisons Board (PPB) has put on notice owners and managers of supermarkets, cosmetic shops, online outlets, and other general retailers, warning against the sale of unregistered or ...

The WHO’s 2025 guidelines mark a milestone for the pharmaceutical cold chain. They draw a clear distinction between ...

DGDA pursuing WHO’s ML-3 accreditation since 2016, which recognizes a country’s drug regulatory authority on the global stage ...

The agency’s sweeping rollout and staff challenge underscore rising momentum behind agentic AI: advanced, multiagent systems ...

A range of blockbuster weight-loss and diabetes drugs could help shift the trajectory of the global obesity epidemic, which ...

Pharmaceutical companies are accused of abusing the patent system to keep drug prices high. Patent manipulation can delay the availability of cheaper generic alternatives for life-saving medications.

For days now, an opulent wedding in Udaipur has captivated attention not just in India but across global media. The lavish festivities, set against the royal backdrop of Rajasthan’s most sought-after ...

As the researchers behind Pfizer and Astellas' Padcev and Merck's Keytruda have taken victory laps on the heels of the positive readout of Keynote-905 study—also known as EV-303—terms like ...

Weight loss pills could account for 25% of the market share over the long term. The GLP-1 market is expected to grow to $100 billion by 2030. New GLP-1 oral versions could receive FDA approval by the ...

In this week’s edition of InnovationRx, we look at the biotech deal frenzy, Recursion’s incoming CEO, the infant formula botulism outbreak, and more. To get it in your inbox, subscribe here. Merck ...

Weight loss pills could account for 25% of the market share over the long term. The GLP-1 market is expected to grow to $100 billion by 2030. New GLP-1 oral versions could receive FDA approval by the ...

Members of the Sackler family who own OxyContin maker Purdue Pharma must pay billions of dollars to settle a flood of lawsuits over the harms of opioids, under a new deal that was formally approved by ...